Doctor profile · Federal record
Dr. Charyse Sindler, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · St Petersburg, FL
- NPI 1821034836
- Accepts Medicare
- 38 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
620 10Th St N Ste 3E
St Petersburg, FL 337051407
(727) 824-8251
fax (727) 824-8271
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- August 15, 2022
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Florida #ME118394
- Medicaid
- FL #111592800
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1821034836. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
806
Distinct HCPCS
7
Medicare allowed
$84,686
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 486 | 217 | $123 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 113 | 45 | $34 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 82 | 64 | $173 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 66 | 44 | $3 | |
83036 |
Hemoglobin a1c level | 25 | 20 | $10 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 21 | 21 | $164 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 13 | 13 | $217 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 103. This provider delivers 7.8× the peer median.Open Payments
Industry payments received
All-time total
$2,786
Transactions
115
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 18 | $314.54 | |
| Lilly USA, LLC | 20 | $277.24 | |
| ABBVIE INC. | 10 | $230.04 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $204.54 | |
| Abbott Laboratories | 10 | $201.04 | |
| Amgen Inc. | 11 | $190.46 | |
| Kyowa Kirin, Inc. | 3 | $174.47 | |
| Insulet Corporation | 2 | $142.93 | |
| Novartis Pharmaceuticals Corporation | 6 | $135.78 | |
| BETA BIONICS, INC. | 5 | $121.71 | |
| Alexion Pharmaceuticals, Inc. | 4 | $119.24 | |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $97.07 | |
| Amneal Pharmaceuticals LLC | 4 | $92.24 | |
| SANOFI-AVENTIS U.S. LLC | 4 | $87.23 | |
| Corcept Therapeutics | 4 | $84.98 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,170
Patients
613
Total drug cost
$1,315,267
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 339 | 84 | $5,323 |
| Atorvastatin Calcium | Generic | 227 | 66 | $3,703 |
| Jardiance (Empagliflozin) | Brand | 203 | 52 | $275,598 |
| Trulicity (Dulaglutide) | Brand | 181 | 42 | $315,691 |
| Synthroid (Levothyroxine Sodium) | Brand | 167 | 35 | $16,080 |
| Ozempic (Semaglutide) | Brand | 159 | 43 | $258,436 |
| Metformin Hcl | Generic | 136 | 46 | $1,475 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 117 | 33 | $162,501 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 116 | 37 | $2,182 |
| Unithroid (Levothyroxine Sodium) | Brand | 107 | 29 | $4,766 |
Hospital affiliations
Frequently asked questions
What is Dr. Charyse Sindler's medical specialty?
Dr. Charyse Sindler practices Endocrinology, Diabetes & Metabolism Physician in St Petersburg, FL.
Where does Dr. Charyse Sindler practice?
Dr. Charyse Sindler practices at 620 10Th St N Ste 3E, St Petersburg, FL 337051407. Office phone: 7278248251.
What is Dr. Charyse Sindler's NPI?
Dr. Charyse Sindler's National Provider Identifier (NPI) is 1821034836, issued by NPPES.
Does Dr. Charyse Sindler accept Medicare assignment?
Yes. Dr. Charyse Sindler accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Charyse Sindler commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.